CLINICAL-BENEFIT-RESPONSE AND MECHANISMS OF PATIENTS WITH MALIGNANT DIGESTIVE TRACT TUMORS TREATED WITH OCTREOTIDE[J]. Journal of Clinical Medicine in Practice, 2003, (4): 296-299. DOI: 10.3969/j.issn.1672-2353.2003.04.003
|
Citation:
|
CLINICAL-BENEFIT-RESPONSE AND MECHANISMS OF PATIENTS WITH MALIGNANT DIGESTIVE TRACT TUMORS TREATED WITH OCTREOTIDE[J]. Journal of Clinical Medicine in Practice, 2003, (4): 296-299. DOI: 10.3969/j.issn.1672-2353.2003.04.003
|
CLINICAL-BENEFIT-RESPONSE AND MECHANISMS OF PATIENTS WITH MALIGNANT DIGESTIVE TRACT TUMORS TREATED WITH OCTREOTIDE[J]. Journal of Clinical Medicine in Practice, 2003, (4): 296-299. DOI: 10.3969/j.issn.1672-2353.2003.04.003
|
Citation:
|
CLINICAL-BENEFIT-RESPONSE AND MECHANISMS OF PATIENTS WITH MALIGNANT DIGESTIVE TRACT TUMORS TREATED WITH OCTREOTIDE[J]. Journal of Clinical Medicine in Practice, 2003, (4): 296-299. DOI: 10.3969/j.issn.1672-2353.2003.04.003
|
DownLoad: